Charles Schwab Investment Management Inc Paratek Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $194,221 - $346,905	-112,267 Reduced 86.58%	17,405 $34,000
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $20,635 - $33,480	7,019 Added 5.72%	129,672 $386,000
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $25,685 - $33,448	6,311 Added 5.42%	122,653 $551,000
Q3 2021 Nov 16, 2021	SELL	$4.7 - $7.24 $875,741 - $1.35 Million	-186,328 Reduced 61.56%	116,342 $566,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $191,565 - $307,460	28,130 Added 10.25%	302,670 $2.07 Million
Q1 2021 May 17, 2021	BUY	$6.14 - $8.31 $18,800 - $25,445	3,062 Added 1.13%	274,540 $1.94 Million
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $18,988 - $29,602	4,146 Added 1.55%	271,478 $1.7 Million
Q3 2020 Nov 13, 2020	BUY	$4.19 - $6.69 $23,790 - $37,985	5,678 Added 2.17%	267,332 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $107,089 - $188,217	36,057 Added 15.98%	261,654 $1.37 Million
Q1 2020 May 15, 2020	BUY	$2.67 - $4.97 $65,599 - $122,107	24,569 Added 12.22%	225,597 $711,000
Q4 2019 Feb 07, 2020	BUY	$2.93 - $4.5 $23,864 - $36,652	8,145 Added 4.22%	201,028 $811,000
Q3 2019 Nov 08, 2019	BUY	$3.08 - $5.76 $81,419 - $152,265	26,435 Added 15.88%	192,883 $834,000
Q2 2019 Aug 09, 2019	BUY	$3.47 - $6.32 $59,878 - $109,057	17,256 Added 11.57%	166,448 $665,000
Q1 2019 May 14, 2019	SELL	$5.36 - $7.24 $44,718 - $60,403	-8,343 Reduced 5.3%	149,192 $800,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $9,561 - $23,107	-1,992 Reduced 1.25%	157,535 $809,000
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $175,542 - $212,397	19,397 Added 13.84%	159,527 $1.55 Million
Q2 2018 Aug 08, 2018	BUY	$10.2 - $13.9 $116,116 - $158,237	11,384 Added 8.84%	140,130 $1.43 Million
Q1 2018 May 07, 2018	BUY	$12.65 - $18.85 $460,207 - $685,763	36,380 Added 39.39%	128,746 $1.67 Million
Q4 2017 Jan 17, 2018	BUY	$17.45 - $25.6 $178,024 - $261,171	10,202 Added 12.42%	92,366 $1.65 Million
Q3 2017 Nov 13, 2017	BUY	$18.9 - $28.2 $1.55 Million - $2.32 Million	82,164	82,164 $2.06 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account